Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
20
Number of overlapping holdings
41.7%
% of CANC's 48 holdings also in BBC
19.2%
% of BBC's 125 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus BBC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in BBC |
Overlap | |
|---|---|---|---|---|
 |
MERUS N.V. | 3.2% | 1.1% | 1.1% |
 |
SUMMIT THERAPEUTICS INC | 3.9% | 1.0% | 1.0% |
|
CG ONCOLOGY, INC. | 1.0% | 0.9% | 0.9% |
|
REVOLUTION MEDICINES, INC. | 5.7% | 0.9% | 0.9% |
|
ARCELLX, INC. | 2.9% | 0.9% | 0.9% |
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to BBC
|
ELI LILLY & CO | 5.4% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 5.1% |
|
REVOLUTION MEDICINES, INC. | 4.8% |
|
BRIDGEBIO PHARMA, INC. | 4.5% |
|
NOVARTIS AG | 4.3% |
 |
ASTRAZENECA PLC | 4.2% |
|
BRISTOL-MYERS SQUIBB CO | 4.0% |
|
EXELIXIS INC | 3.8% |
 |
GENMAB A/S SPONSORED ADR | 3.4% |
|
NUVALENT, INC. CLASS A | 3.1% |
CANC Underweight Relative to BBC
|
AKERO THERAPEUTICS, INC. | -1.5% |
|
LIQUIDIA TECHNOLOGIES, INC. | -1.4% |
|
SANA BIOTECHNOLOGY, INC. | -1.3% |
|
XERIS PHARMACEUTICALS INC | -1.3% |
|
ARCUTIS BIOTHERAPEUTICS INC | -1.2% |
 |
PROTHENA CORP PLC | -1.1% |
|
ANAPTYSBIO, INC. | -1.1% |
|
ALLOGENE THERAPEUTICS, INC. | -1.1% |
|
VERVE THERAPEUTICS, INC. | -1.1% |
|
VIR BIOTECHNOLOGY, INC. | -1.1% |